Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
95.70
+2.36 (2.53%)
Jul 7, 2026, 4:00 PM EDT - Market closed
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $5.22 billion as of July 7, 2026. Its market cap has increased by 863.62% in one year.
Market Cap
5.22B
Enterprise Value
3.98B
1-Year Change
863.62%
Ranking
Category
Stock Price
$95.70
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $5.22B, an increase of 3,104.62%. That is a compound annual growth rate of 242.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 5.22B | 195.62% |
| Dec 31, 2025 | 1.77B | 173.85% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
| Sep 12, 2023 | 162.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Definium Therapeutics | 5.88B |
| Erasca | 5.86B |
| Xenon Pharmaceuticals | 5.85B |
| Legend Biotech | 5.42B |
| Travere Therapeutics | 5.35B |
| Celcuity | 5.30B |
| Veradermics | 5.10B |
| Caris Life Sciences | 5.03B |